Episodi

  • The Pharmacology of Study Drugs: Amphetamines, Dopamine, and Cognitive Enhancement
    Nov 2 2026
    Explore how amphetamine-based medications influence dopamine and norepinephrine signaling, why subjective concentration can differ from measurable cognitive improvement, and how dose and sleep deprivation influence outcomes.
    Mostra di più Mostra meno
    3 min
  • Withdrawal or Relapse? Why Antidepressant Discontinuation Can Be Misunderstood
    Nov 1 2026
    Explore the psychological and clinical challenges of distinguishing antidepressant discontinuation symptoms from the return of depression or anxiety. Examine how symptom timing, physical sensations, and emotional changes influence clinical assessment, and why a careful medication history is essential.
    Mostra di più Mostra meno
    4 min
  • When Addiction Treatment Becomes Addiction Maintenance: The Pharmacology Behind Rehab Fraud
    Oct 27 2026
    What happens when a facility entrusted with treating substance-use disorders allegedly helps perpetuate the very addiction it promises to address? This episode examines the neurobiology of opioid and stimulant dependence, withdrawal, craving, and the medications used in evidence-based addiction treatment. We explore how access to drugs, inadequate medical supervision, and repeated treatment disruptions can undermine recovery. The Southern California rehab fraud allegations provide a disturbing backdrop for understanding the difference between legitimate pharmacological treatment and exploiting addiction for financial gain.
    Mostra di più Mostra meno
    3 min
  • SSRIs Compared: Best Diagnoses, Half-Lives, Side Effects, and Prescribing Exceptions
    Oct 26 2026
    Not every SSRI is interchangeable — choosing the right one depends on far more than just the diagnosis in front of you. This episode compares seven SSRIs across their FDA-approved indications for depression, OCD, panic disorder, and generalized anxiety disorder, breaking down half-lives, side-effect profiles, and the prescribing nuances that separate one agent from another. We cover pediatric and geriatric precautions, key drug interactions, discontinuation syndrome, and the risk of serotonin toxicity. Built for PMHNP board prep, this episode walks through how to distinguish these medications in real clinical scenarios and match treatment to patient presentation.
    Mostra di più Mostra meno
    5 min
  • Dopamine Blockade: Why Antipsychotics Work and Why They Cause Side Effects
    Oct 26 2026
    Antipsychotic medications frequently act on dopamine D2 receptors, but blocking these receptors produces different effects depending on where they are located in the brain. This episode examines how dopamine antagonism and partial agonism influence psychotic symptoms, movement disorders, and prolactin secretion. We compare first-generation and second-generation antipsychotics, including haloperidol, risperidone, aripiprazole, and clozapine. The discussion explains why understanding receptor pharmacology is essential for balancing therapeutic benefits against adverse effects.
    Mostra di più Mostra meno
    4 min
  • Why Prozac, Zoloft, and Lexapro Affect Patients Differently
    Oct 21 2026
    Explore pharmacokinetics, CYP450 metabolism, serotonin transporter inhibition, and receptor adaptations. Explain why medications within the same class can differ in tolerability and interaction potential.
    Mostra di più Mostra meno
    6 min
  • Why Antidepressants Take Weeks to Work
    Oct 20 2026
    Explore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant response cannot be reduced to a simple chemical imbalance.
    Mostra di più Mostra meno
    5 min
  • Methamphetamine vs. Adderall: How Different Are They Really?
    Oct 19 2026
    Methamphetamine and prescription amphetamines share important pharmacological properties, but differences in chemical structure, dosing, delivery, and medical supervision can profoundly affect their risks. This episode compares methamphetamine, Adderall, and Ritalin through the lens of neurotransmitter activity and clinical pharmacology. We also explore why methamphetamine itself retains a limited legitimate medical role despite its association with severe addiction.
    Mostra di più Mostra meno
    5 min